Reymann, S., Schoretsanitis, G., Egger, S. T., Mohonko, A., Kirschner, M., Vetter, S., . . . Burrer, A. (2022). Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland. Journal of Personalized Medicine, 12(3), 441. https://doi.org/10.3390/jpm12030441
Chicago Style (17th ed.) CitationReymann, Stephan, Georgios Schoretsanitis, Stephan T. Egger, Alexey Mohonko, Matthias Kirschner, Stefan Vetter, Philipp Homan, Erich Seifritz, and Achim Burrer. "Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland." Journal of Personalized Medicine 12, no. 3 (2022): 441. https://doi.org/10.3390/jpm12030441.
MLA (9th ed.) CitationReymann, Stephan, et al. "Use of Long-Acting Injectable Antipsychotics in Inpatients with Schizophrenia Spectrum Disorder in an Academic Psychiatric Hospital in Switzerland." Journal of Personalized Medicine, vol. 12, no. 3, 2022, p. 441, https://doi.org/10.3390/jpm12030441.